Genetic and non‐genetic drug resistance: Darwin or Lamarck?
Drug resistance represents a major limitation to the long‐term efficacy of anti‐cancer treatments. The commonly accepted view is that the selection of inheritable genetic mechanisms governs the development of secondary resistance. However, compelling evidence suggests an important role for adaptive...
Main Author: | Mariangela Russo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13601 |
Similar Items
-
Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance
by: Ali A. Rabaan, et al.
Published: (2023-02-01) -
The Evolutionary Process in Lamarckism and Darwinism: similarities and differences
by: Sayyed Mojtaba Hosseini, et al.
Published: (2022-08-01) -
Transhumanism and Evolution. Considerations on Darwin, Lamarck and Transhumanism
by: Filip Bardziński
Published: (2014-09-01) -
Editorial: Non-genetic adaptive drug resistance in cancer
by: Michaël Cerezo, et al.
Published: (2022-11-01) -
Cisplatin Resistance: Genetic and Epigenetic Factors Involved
by: Yuliannis Lugones, et al.
Published: (2022-09-01)